Detalles de la búsqueda
1.
Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.
Ann Oncol
; 28(10): 2581-2587, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961848
2.
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.
Ann Oncol
; 28(2): 368-376, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27687304
3.
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial.
Ann Oncol
; 26(2): 415-21, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25411413
4.
Cost and threshold analysis of an HIV/STI/hepatitis prevention intervention for young men leaving prison: Project START.
AIDS Behav
; 17(8): 2676-84, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22124581
5.
Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.
J Exp Med
; 171(5): 1567-79, 1990 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2185329
6.
Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response.
Science
; 194(4266): 737-8, 1976 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-185696
7.
Decreased H2 histamine response of granulocytes of asthmatic patients.
J Clin Invest
; 59(6): 1080-7, 1977 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-193871
8.
Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.
J Natl Cancer Inst
; 80(18): 1451-61, 1988 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-3263508
9.
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity.
J Natl Cancer Inst
; 80(1): 60-3, 1988 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-3257526
10.
Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
Cancer Res
; 49(13): 3680-8, 1989 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2471587
11.
Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.
Cancer Res
; 48(9): 2561-7, 1988 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-3258545
12.
Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Cancer Res
; 50(9): 2683-91, 1990 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-1691679
13.
Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity.
Cancer Res
; 49(23): 6832-9, 1989 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2819723
14.
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.
Oncogene
; 35(10): 1225-35, 2016 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26073081
15.
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.
Circulation
; 104(3): 257-62, 2001 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-11457741
16.
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.
J Clin Oncol
; 18(2): 371-5, 2000 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10637252
17.
Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.
J Clin Oncol
; 17(8): 2541-5, 1999 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10561320
18.
Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.
J Clin Oncol
; 12(1): 176-83, 1994 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-8270975
19.
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.
J Clin Oncol
; 19(9): 2370-80, 2001 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11331315
20.
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
J Clin Oncol
; 19(3): 634-44, 2001 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11157013